There has been great interest in the browning of fat for the treatment of obesity. Although β-lapachone (BLC) has potential therapeutic effects on obesity, the fat browning effect and thermogenic capacity of BLC on obesity have never been demonstrated. Here, we showed that BLC stimulated the browning of white adipose tissue (WAT), increased the expression of brown adipocyte-specific genes (e.g., uncoupling protein 1 [UCP1]), decreased body weight gain, and ameliorated metabolic parameters in high-fat diet-fed mice. Consistently, BLCtreated mice showed significantly higher energy expenditure compared to control mice. In vitro, BLC increased the expression of brown adipocyte-specific genes in stromal vascular fraction-differentiated adipocytes. BLC also controlled the expression of miR-382, which led to the up-regulation of its direct target, Dio2. Up-regulation of miR-382 markedly inhibited the differentiation of adipocytes into beige adipocytes, whereas BLC recovered beige adipocyte differentiation and increased the expression of Dio2 and UCP1. Our findings suggest that the BLC-mediated increase in the browning of WAT and thermogenic capacity of BAT significantly results in increases in energy expenditure. Browning of WAT by BLC was partially controlled via the regulation of miR-382 targeting Dio2 and may lead to the prevention of diet-induced obesity.
difference between groups analysis. The Student's t-test was used to compare the differences between two groups. Comparison with a P value <0.05 was considered significant.
Results

BLC decreases adiposity but increases energy expenditure in HFD-fed mice
After 11 weeks on the experimental diet, the final mean body weight of HBLC-fed mice was significantly lower than that of HFD-or LBLC-fed mice (HFD, 36.3±1.1 g; LBLC, 30.3±0.9 g; HBLC, 27.2±0.5 g; Fig. 1A ). The average weekly food intake was not significantly different among groups (Fig. 1B) , suggesting that the reduction in body weight gain in LBLC and HBLC groups is not due to decreases in food consumption. To determine whether the weight-reducing effect of BLC was due to decreases in adipose tissue, the individual adipose tissue depot was scanned and quantified by micro-CT scanning, which was then used to generate a series of cross-sectional X-ray images. Consistent with the decrease in body weight, micro-CT images showed dramatic decreases in fat accumulation with BLC treatment (n=3, fat mass/total body mass, HFD=45.8±1.6%; LBLC=30.3±2.7%; HBLC=22.2±1.9%) (Fig. 1C) . Moreover, the weight of WAT in BLC-treated mice was significantly decreased. In addition, BLC supplementation significantly decreased the size of adipocytes (Fig. 1D ). BLC also decreased lipid accumulation and increased the expression of thermogenic genes in the liver ( Supplementary Fig. 1 ). To investigate whether BLC elicits a beneficial metabolic effect, we conducted the OGTT and IPITT. Compared to HFD mice, BLC-treated mice had lower blood glucose concentrations after glucose or insulin administration, showing a significantly low area under the curve ( Fig. 1E and F) . In particular, the HBLC group showed insulin and leptin levels that were markedly reduced by 73.6% and 80.7%, respectively, compared to the HFD group (Table 1 ). In addition, BLC treatment did not cause any side effects or growth ( Supplementary Fig. 2 ).
To determine whether BLC reduces body weight gain and adiposity by modulating energy expenditure and to understand the mechanism of BLC-induced thermogenesis, we performed indirect calorimetry at room temperature (22°C) or at thermoneutrality (30°C). At 22°C, BLC-treated mice showed significantly higher oxygen consumption and carbon dioxide production throughout the 12-hour dark time, compared with HFD mice ( Fig. 2A and B) . energy expenditure was much lower at 30°C than at 22°C, BLC treatment also elicited a significant increase in metabolic rate at 30°C (Fig. 2D-F) .
BLC induces browning phenotypes in WAT and thermogenesis in BAT
We analyzed the expression of brown adipocyte-specific genes and proteins in the WAT of HFD-induced mice. A significant increase in brown adipocyte-specific genes, including UCP1, PRDM16, PGC1α, Cidea, and Elovl3, was observed in LBLC and HBLC groups (Fig.   3A ). In particular, the expression of UCP1 and Elovl3 mRNA in the scWAT of the HBLC group was 62.5-fold and 24.7-fold higher than that of the HFD group. This increase in expression was also significantly higher in the epididymal WAT (epWAT) of the BLC groups than that of the HFD group (Fig. 3C) . However, the expression of these genes was much higher in the scWAT than in the epWAT. These results are consistent with the findings of Wu et al. (22) . Additionally, brown adipocyte-specific proteins were increased with BLC administration ( Fig. 3B and D) . These increases in the scWAT of HBLC mice were accompanied by profound morphological changes toward a BAT-like phenotype, which was characterized by numerous UCP1-expressing clusters. However, UCP1-expressing adipocytes were not detected in the scWAT of HFD mice. Notably, the scWAT of HBLC mice appeared browner than that of HFD mice (Fig. 3E ). In addition, the size and number of lipid droplets were clearly reduced in the interscapular BAT of the HBLC group (Fig. 3F) , and key thermogenic factors were stimulated ( Fig. 3G and H) 
BLC enhances mitochondrial function and mitochondrial biogenesis
We further evaluated the effect of BLC on mitochondrial function. The morphometric analysis of mitochondria in the gastrocnemius of HBLC mice showed the aggregation of larger mitochondria between adjacent myofibrils and well-organized cristae (Fig. 4A) . HBLC mice also exhibited significantly increased complex II subunit activity and citrate synthase activity in the muscle, resulting in oxidative phosphorylation and higher expression levels of mitochondrial function-related genes ( Fig. 4B-C, E) . Furthermore, BLC induced mitochondrial expansion, as evidenced by increases in mitochondrial DNA (mtDNA) content in HBLC mice (Fig. 4D) . Previous studies have shown that activated mitochondrial function can be induced by cold stress or β-adrenergic stimuli, as well as the expression of brown adipocyte-specific genes (23-25). Exposure of mice to cold temperatures (CE) in this study resulted in an approximately 15-fold increase in UCP1 mRNA levels and a significant increase in UCP1 protein levels in the scWAT of mice compared to room temperature-mice (RT) ( Supplementary Fig. 4A and B) . Mitochondrial function-related genes and UCPs in the skeletal muscle were also significantly induced ( Supplementary Fig. 4C and D) . Overall, we show that cold exposure induced fat browning and activated mitochondrial function; these results are consistent with previous studies (23-25). Therefore, we also suggest that BLC shows comparable effects to cold stimulation on fat browning.
BLC induces brown adipocyte-like phenotypes and enhances mitochondrial function in adipocytes differentiated from SVF.
BLC induced the expression of brown adipocyte-specific genes in the WAT of HFD-induced obese mice in vivo. To confirm whether BLC affects the brown response during adipocyte differentiation, we isolated SVFs and induced differentiation into mature white adipocytes in the presence and absence of BLC (Fig. 5A ). BLC treatment had no effect on adipocyte differentiation (Fig. 5B) . Treatment with BLC led to an up-regulation of brown-specific genes (PRDM16, UCP1, PGC1α, and Cidea) (Fig. 5C, Supplementary Fig. 5 ), and proteins (UCP1 and PGC1α) (Fig. 5D) . Also, BLC strongly induced the expression of mitochondrial function-related genes and increased mtDNA content (Fig 5E and F) . Furthermore, basal and maximal OCRs were higher in adipocytes from BLC-treated SVFs, although these increases were not statistically significant (Fig. 5G ). Higher degrees of UCP1-stained adipocytes were observed in the presence of BLC when compared to control adipocytes, although BLC treatment did not show any effect on lipid droplet formation (Fig. 5H ).
BLC down-regulates the expression of miR-382, and Dio2 is the direct target of miR-382
To understand the mechanism by which BLC exerts its fat browning effect, TLDAs were performed. miRNAs that exhibit altered expression levels in the igWAT after BLC treatment were identified. Expression clusters of miRNAs that were related to brown fat differentiation or adipocyte browning were obtained by hierarchical clustering analysis (Fig. 6A) . miR-382, miR-133a, miR-133b, miR-27b, and miR-155 were identified as negative regulators of fat browning, as they were down-regulated in the scWAT of BLC-fed mice (Fig. 6A ).
Quantitative RT-PCR results show that miR-382 expression was significantly down-regulated in the scWAT of BLC-fed mice (Fig. 6B) . Therefore, we hypothesized that miR-382 might be involved as a negative regulator in the expression of brown fat-specific genes. Next, we investigated the potential target genes of miR-382 that may stimulate fat browning.
Bioinformatics analyses that were generated using the miRWalk, TargetScan, and miRBase databases revealed that Dio2 was a putative target gene of miR-382, and the miRNA 5´-seed sequence shared homology with Dio2 (Fig. 6C ). Dio2 activates the conversion of thyroxin (T4) to 3,3´,5-triiodothyronine (T3), which accelerates the adrenergic response and leads to energy expenditure (26-28). We observed a significant increase in Dio2 mRNA in the scWAT of BLC-fed mice (Fig. 6D ). To confirm whether BLC also down-regulates the expression of miR-382 in vitro, we induced the differentiation of mature white adipocytes from SVFs treated with BLC. BLC significantly down-regulated miR-382 and up-regulated Dio2 mRNA expression in white adipocytes ( Fig. 6E and F) .
To investigate the effect of miR-382 on Dio2 expression, we activated miR-382 expression by transfecting SVFs with mimic-miR-382 (50 nM) for 2 days. Transfection with mimic-miR-382 dramatically increased miR-382 expression ( Fig. 6G ) and down-regulated Dio2 mRNA expression (Fig. 6H ). We performed luciferase reporter assays to determine whether miR-382 specifically targets Dio2 by directly binding to its 3´UTR in HEK-293T cells (Fig. 6I) . The introduction of mimic-miR-382 significantly repressed the Dio2 3´UTR construct compared to that observed in control construct-transfected cells. Repressed luciferase binding activity was abrogated when the seed sequences in the 3´UTR were mutated (uAACcc). Furthermore, we investigated whether Dio2 is responsible for mediating the browning effect of BLC. Transfection with Dio2 siRNA successfully inhibited the expression of brown-specific UCP1 and Cidea. Moreover, the browning effect of BLC was blunted by inhibition of Dio2 ( Fig. 6J and K) . These findings suggest that BLC increases the browning effect by mediating Dio2.
miR-382 inhibits beige adipocyte differentiation but BLC recovers the browning of adipocytes
To investigate the effect of miR-382 on beige adipocyte differentiation, we transfected SVF cells with mimic-miR-382 or mimic-ctrl for 48 hours. The brown adipocyte differentiation cocktail was used to differentiate transfected cells into beige adipocytes. During the 8 days of differentiation, the cells were treated with or without 1 µM BLC. In accordance with the marked activation of miR-382 by mimic-miR-382 (Fig. 7A) , mimic-miR-382-transfected adipocytes exhibited significant down-regulation of Dio2, UCP1, and peroxisome proliferator-activated receptor (PPAR)γ mRNA and protein levels ( Fig. 7B-E) . These data strongly suggest that miR-382 is a negative regulator of beige adipocyte differentiation.
However, treatment with 1 µM BLC recovered the miR-382-induced depression of beige adipocyte differentiation, and the expression of Dio2, UCP1, and PPARγ was up-regulated significantly ( Fig. 7B-E) . Furthermore, treatment with 1 µM BLC significantly down- Importantly, we provided compelling evidence to demonstrate the anti-obesity and fat browning effects of BLC. BLC significantly decreased body weight gain, which may be due to decreases in body fat accumulation. In addition, BLC increased the expression of brown adipocyte-specific genes and induced morphological changes toward a BAT-like phenotype in the scWAT. Numerous clusters of UCP1-expressing cells, which are typical features of BAT (33; 34), were observed. These findings strongly suggest that BLC has a fat browning effect. Thermogenesis predominantly involves classical BAT, which expresses much higher levels of UCP1 than the scWAT (35). In this study, we also found that UCP1 mRNA expression was much higher in BAT than in scWAT ( Supplementary Fig. 3 ). However, BLC induced a robust increase in UCP1 expression in scWAT (over 60-fold increase in scWAT vs. 2.3-fold increase in BAT). In addition, the BLC-mediated induction of thermogenic capacity was also observed in BAT. Although the tissue source of total main thermogenic capacity remains unclear, our results suggest that BLC synergistically induces increases in energy expenditure in scWAT and BAT.
Furthermore, enhanced mitochondrial function is closely related to brown fat function (36). Mitochondrial function can impact whole-body metabolism, and this is most evident in the muscle (18). In the present study, BLC treatment induced morphological changes in the mitochondria, as analyzed by TEM in the gastrocnemius muscle. The combination of increased mitochondrial size and well-organized cristae in the skeletal muscle, as well as increases in mtDNA contents, citrate synthase activities, and oxidative capacity in BAT and scWAT, indicate that BLC has a widespread effect on mitochondrial function. BLC-induced increases in mtDNA contents in SVF-derived adipocytes in vitro also suggest that BLC has an effect on mitochondrial function.
BLC has been shown to activate Sirt1 and AMPK1, thereby ameliorating obesity (16).
Indeed, BLC increased the expression of phosphorylated AMPK and UCP1 in this study.
However, this increase by BLC was inhibited by AMPK siRNA in SVF-derived adipocytes ( Supplementary Fig. 6 ). Lee et al. (37) also reported that BLC increases metabolic rates partly by increasing UCPs. These results suggest that the BLC-mediated increase in mitochondrial function and fat browning might contribute considerably to favorable metabolic profiles against obesity.
Moreover, BLC activated the thermogenic capacity, as an increase in energy expenditure was observed at both room temperature (22°C) and thermoneutral conditions (30°C). This raises the possibility that significant increases in energy expenditure by BLC at 30°C might be caused by a Dio2-mediated elevation. These results help us to further understand the mechanisms of BLC on thermogenic activity.
Through the targeted study of miRNAs, we identified miR-382 as a negative regulator of fat browning, and Dio2 was identified as the direct target of miR-382. Typically, Dio2 converts T4 to its active metabolite, T3 (38 However, treatment with BLC recovered the expression of these brown adipocyte-specific genes, including Dio2, in SVF-differentiated adipocytes ( Supplementary Fig. 7A-D) . As the actions of Dio2 and T3 appeared to be important for the browning effect of BLC, we investigated T3 levels in the serum and tissues. Although T3 levels in the serum were not affected by BLC treatment, T3 was increased significantly in the scWAT and BAT ( Supplementary Fig. 7E ). This may be due to the high tissue specificity of Dio2 (42). We also confirmed that the browning effect of BLC was blunted by the thyroid hormone receptor (TR)
antagonist, 1-850 ( Supplementary Fig. 7F ). Based on the importance of T3 for UCP1 gene expression, we might suggest that T3-mediated transcriptional regulation is involved in the browning effect of BLC.
In addition, BLC down-regulated the expression of miR-382, which is a negative regulator of fat browning, and up-regulated the expression of Dio2. Therefore, BLC may enhance fat browning and energy expenditure, at least in part, by controlling the targeting of Dio2 by miR-382. Phosphatase and tensin homolog (PTEN) has also been reported to be a functional target gene of miR-382 (43); PTEN increases brown adipose function and energy expenditure (44). We observed increases in PTEN protein levels in the adipose tissue of BLC-supplemented mice (Fig. 2) . Therefore, further studies investigating possible mechanisms involving miR-382 and PTEN are warranted.
Overall, our results show that BLC stimulated browning and thermogenesis in WAT and BAT, respectively. These led to increases in energy expenditure. The effect of BLC on the browning of WAT was partially mediated via the regulation of miR-382, which targeted Dio2
Page 16 of 43 Diabetes (Fig. 7F) . These findings suggest novel roles for BLC in the prevention of obesity. Moreover, these results extend our focus on dietary therapeutic compounds and fat browning, and suggest a new approach for the treatment of obesity and metabolic disorders by beige adipocyte induction. 
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